Indraprastha Medical Corporation Limited — Board Meeting, 06-08-2025: Outcome of Board Meeting

Indraprastha Medical Corporation's Board met and approved the financial results for the quarter ended June 30, 2025. Revenue from operations stood at Rs 365.06 Cr, with a profit after tax of Rs 51.46 Cr and EPS of Rs 5.61.

The Board appointed Mr. Sudhir Jalan as an Independent Director for a five-year term, pending shareholder approval at the upcoming 37th Annual General Meeting (AGM) on September 24, 2025. The record date for the dividend for FY2024-25 and AGM purposes is September 18, 2025. The Board also re-appointed Cost Auditors and appointed Secretarial Auditors for multi-year terms.